Recent Quotes
My Watchlist
Indicators
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Edwards Lifesciences (NY:EW)

82.81 +0.62 (+0.75%)
Streaming Delayed Price Updated: 3:45 PM EDT, Oct 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,240,401
Open 84.50
Bid (Size) 82.79 (5)
Ask (Size) 82.82 (4)
Prev. Close 82.19
Today's Range 81.80 - 84.66
52wk Range 64.89 - 83.25
Shares Outstanding 587,100,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
A Preview Of Edwards Lifesciences's Earnings
 
Via Benzinga
Nvidia To Rally Around 37%? Here Are 10 Top Analyst Forecasts For Wednesday
 
Via Benzinga

Performance

YTD
+14.1%
+14.1%
1 Month
+7.3%
+7.3%
3 Month
+2.9%
+2.9%
6 Month
+8.6%
+8.6%
1 Year
+20.8%
+20.8%

More News

Read More
This Edwards Lifesciences Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday
Via Benzinga
These S&P500 stocks have an unusual volume in today's session
Via Chartmill
Halper Sadeh LLC Encourages Edwards Lifesciences Corporation Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via Business Wire
Exploring the top movers within the S&P500 index during today's session.
Via Chartmill
Successful Patient Outcomes Demonstrated With Edwards’ SAPIEN M3 and EVOQUE Systems, New Data Presented at TCT 2025
From Edwards Lifesciences Corporation
Via Business Wire
Edwards SAPIEN 3 TAVR Delivers Proven Long-term Benefits and Valve Performance, New Data Presented at TCT 2025
From Edwards Lifesciences Corporation
Via Business Wire
Edwards Lifesciences to Host Earnings Conference Call on October 30, 2025
From Edwards Lifesciences Corporation
Via Business Wire
EW Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EW
From The Rosen Law Firm, P.A.
Via Business Wire
EW Investor News: Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EW
From The Rosen Law Firm PA
Via GlobeNewswire
EW Investor News: Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EW
From The Rosen Law Firm PA
Via GlobeNewswire
Here's How Much $100 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth Today
Via Benzinga
Wealth Manager Doubles Down on Adobe, According to Recent SEC Filing
Via The Motley Fool
Topics Regulatory Compliance
Wealth Manager Takes Big New Stake in Visa, According to Latest Filing
Via The Motley Fool
Topics Regulatory Compliance
EW Investor News: Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EW
From The Rosen Law Firm PA
Via GlobeNewswire
Which S&P500 stocks are gapping on Wednesday?
Via Chartmill
Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 20 Years
Via Benzinga
EW Investor News: If You Have Suffered Losses in Edwards Lifesciences Corporation (NYSE: EW), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
From The Rosen Law Firm PA
Via GlobeNewswire
EW Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EW
From Rosen Law Firm
Via Business Wire
Analyst Expectations For Edwards Lifesciences's Future
Via Benzinga
EDWARDS (EW) ALERT: Bragar Eagel & Squire, P.C. is Investigating Edwards Lifesciences Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Here Are Billionaire Ken Griffin's 5 Biggest Stock Holdings
Via The Motley Fool
Topics Artificial Intelligence Energy
3 Healthcare Pathbreakers With Long-Term Tailwinds
Via MarketBeat
Updated ESC/EACTS Guidelines Mark Advancement in Structural Heart Disease Care
From Edwards Lifesciences Corporation
Via Business Wire

Frequently Asked Questions

Is Edwards Lifesciences publicly traded?
Yes, Edwards Lifesciences is publicly traded.
What exchange does Edwards Lifesciences trade on?
Edwards Lifesciences trades on the New York Stock Exchange
What is the ticker symbol for Edwards Lifesciences?
The ticker symbol for Edwards Lifesciences is EW on the New York Stock Exchange
What is the current price of Edwards Lifesciences?
The current price of Edwards Lifesciences is 82.81
When was Edwards Lifesciences last traded?
The last trade of Edwards Lifesciences was at 10/29/25 03:45 PM ET
What is the market capitalization of Edwards Lifesciences?
The market capitalization of Edwards Lifesciences is 48.61B
How many shares of Edwards Lifesciences are outstanding?
Edwards Lifesciences has 49B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.